Prostaglandin D2 inhibits collagen secretion from lung fibroblasts by activating the DP receptor

Journal of Pharmacological Sciences

Volumn 121, Issue 4, 2013, Pages 312-317

  Ayabe, Shinya ^a   Kida, Taiki ^a   Hori, Masatoshi ^a   Ozaki, Hiroshi ^a   Murata, Takahisa ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

Collagen secretion; Lung fibroblast; Prostaglandin D2; Prostanoid DP receptor; TGF

Indexed keywords

5 (6 CARBOXYHEXYL) 1 (3 CYCLOHEXYL 3 HYDROXYPROPYL)HYDANTOIN; 8 BROMO 2' O METHYLADENOSINE 3',5'CYCLIC AMP; ADENOSINE PHOSPHATE; ANTIPORTER; BUCLADESINE; COLLAGEN TYPE 1; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; DP RECEPTOR; FORSKOLIN; N6 PHENYL CYCLIC AMP; PROSTAGLANDIN D2; PROSTANOID RECEPTOR; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ARTICLE; BIOACCUMULATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; LUNG FIBROBLAST; PROTEIN LOCALIZATION; PROTEIN SECRETION; SEQUENCE HOMOLOGY; TH2 CELL;

EID: 84877620877     PISSN: 13478613     EISSN: 13478648     Source Type: Journal    
DOI: 10.1254/jphs.12275FP     Document Type: Article

References (29)

1. Murakami M, Matsumoto R, Urade Y, Austen KF, Arm JP. c-kit ligand mediates increased expression of cytosolic phospholipase A2, prostaglandin endoperoxide synthase-1, and hematopoietic prostaglandin D2 synthase and increased IgE-dependent prostaglandin D2 generation in immature mouse mast cells. J Biol Chem. 1995;270:3239-3246.
2. Tanaka K, Ogawa K, Sugamura K, Nakamura M, Takano S, Nagata K. Cutting edge : differential production of prostaglandin D2 by human helper T cell subsets. J Immunol. 2000;164: 2277-2280.
3. Narumiya S, Sugimoto Y, Ushikubi F. Prostanoid receptors: structures, proper ties, and functions. Physiol Rev. 1999;79: 1193-1226.
4. Hayaishi O, Matsumura H, Urade Y. Prostaglandin D synthase is the key enzyme in the promotion of physiological sleep. J Lipid Mediat. 1993;6:429-431.
5. Hardy CC, Robinson C, Tattersfield AE, Holgate ST. The bronchoconstrictor effe ct of inhaled prostaglandin D2 in normal and asthmatic men. N Engl J Med. 1984;311:209-213.
6. Robinson C, Holgate ST. Mast cell-dependent inflammatory mediators and their pu tative role in bronchial asthma. Clin Sci (Lond). 1985;68:103-112.
7. Csanky E, Ruhl R, Scholtz B, Vasko A, Takacs L, Hempel WM. Lipid metabolite leve ls of prostaglandin D2 and eicosapentaenoic acid recovered from bronchoalveolar lavage fluid correlate with lung function of chronic obstructive pulmonary disease patients and controls. Electrophoresis. 2009;30:1228-1234.
8. Matsuoka T, Hirata M, Tanaka H, Takahashi Y, Murata T, Kabashima K, et al. Prosta glandin D2 as a mediator of allergic asthma. Science. 2000;287:2013-2017.
9. Darby IA, Hewitson TD. Fibroblast differentiation in wound healing and fibrosis. I nt Rev Cytol. 2007;257:143-179.
10. Gharaee-Kermani M, Hu B, Phan SH, Gyetko MR. Recent advances in molecular targets and treatment of idiopathic pulmonary fibrosis: focus on TGFbeta signaling and the myofibroblast. Curr Med Chem. 2009;16:1400-1417.
11. Border WA, Noble NA. Transforming growth factor beta in tissue fibrosis. N Engl J M ed. 1994;331:1286-1292.
12. Oga T, Matsuoka T, Yao C, Nonomura K, Kitaoka S, Sakata D, et al. Prostaglandin F(2a lpha) receptor signaling facilitates bleomycin-induced pulmonary fibrosis independently of transforming growth factor-beta. Nat Med. 2009;15:1426-1430.
13. Huang S, Wettlaufer SH, Hogaboam C, Aronoff DM, Peters- Golden M. Prostaglandin E(2) i nhibits collagen expression and proliferation in patient-derived normal lung fibroblasts via E prostanoid 2 receptor and cAMP signaling. Am J Physiol Lung Cell Mol Physiol. 2007;292:L405-L413.
14. Rennard SI, Berg R, Martin GR, Foidart JM, Robey PG. Enzymelinked immunoassay (ELISA) for connective tissue components. Anal Biochem. 1980;104:205-214.
15. Zhang K, Rekhter MD, Gordon D, Phan SH. Myofibroblasts and their role in lung collagen gene expression during pulmonary fibrosis. A combined immunohistochemical and in situ hybridization study. Am J Pathol. 1994;145:114-125.
16. Huang SK, Wettlaufer SH, Chung J, Peters-Golden M. Prostaglandin E2 inhibits specific lu ng fibroblast functions via selective actions of PKA and Epac-1. Am J Respir Cell Mol Biol. 2008;39:482-489.
17. Haselden BM, Larche M, Meng Q, Shirley K, Dworski R, Kaplan AP, et al. Late asthmatic rea ctions provoked by intradermal injection of T-cell peptide epitopes are not associated with bronchial mucosal infiltration of eosinophils or T(H)2-type cells or with elevated concentrations of histamine or eicosanoids in bronchoalveolar fluid. J Allergy Clin Immunol. 2001;108: 394-401.
18. Hartert TV, Dworski RT, Mellen BG, Oates JA, Murray JJ, Sheller Jr. Prostaglandin E(2) decreases allergen-stimulated release of prostaglandin D(2) in airways of subjects with asthma. Am J Respir Crit Care Med. 2000;162:637-640.
19. Mandal AK, Zhang Z, Ray R, Choi MS, Chowdhury B, Pattabiraman N, et al. Uteroglobin represses allergen-induced inflammatory response by blocking PGD2 receptor-mediated functions. J Exp Med. 2004;199:1317-1330.
20. Hammad H, Kool M, Soullie T, Narumiya S, Trottein F, Hoogsteden HC, et al. Activation of the D prostanoid 1 receptor suppresses asthma by modulation of lung dendritic cell function and induction of regulatory T cells. J Exp Med. 2007;204: 357-367.
21. Lamyel F, Warnken-Uhlich M, Seemann WK, Mohr K, Kostenis E, Ahmedat AS, et al. The beta2-subtype of adrenoceptors mediates inhibition of pro-fibrotic events in human lung fibroblasts. Naunyn Schmiedebergs Arch Pharmacol. 2011;384:133- 145.
22. K olodsick JE, Peters-Golden M, Larios J, Toews GB, Thannickal VJ, Moore BB. Prostaglandin E2 inhibits fibroblast to myofibroblast transition via E. prostanoid receptor 2 signaling and cyclic adenosine monophosphate elevation. Am J Respir Cell Mol Biol. 2003;29:537-544.
23. La udanna C, Campbell JJ, Butcher EC. Elevation of intracellular cAMP inhibits RhoA activation and integrin-dependent leukocyte adhesion induced by chemoattractants. J Biol Chem. 1997; 272:24141-24144.
24. de Rooij J, Zwartkruis FJ, Verheijen MH, Cool RH, Nijman SM, Wittinghofer A, et al. Epac is a Rap1 guanine-nucleotideexchange factor directly activated by cyclic AMP. Nature. 1998; 396:474-477.
25. Yoko yama U, Patel HH, Lai NC, Aroonsakool N, Roth DM, Insel PA. The cyclic AMP effector Epac integrates pro- and anti-fibrotic signals. Proc Natl Acad Sci U S A. 2008;105:6386- 6391.
26. Villa rreal F, Epperson SA, Ramirez-Sanchez I, Yamazaki KG, Brunton LL. Regulation of cardiac fibroblast collagen synthesis by adenosine: roles for Epac and PI3K. Am J Physiol Cell Physiol. 2009;296:C1178-C1184.
27. Yin F, Wang YY, Du JH, Li C, Lu ZZ, Han C, et al. Noncanonical cAMP pathway and p38 MAPK mediate beta2-adrenergic receptor-induced IL-6 production in neonatal mouse cardiac fibroblasts. J Mol Cell Cardiol. 2006;40:384-393.
28. Choi YH, Lee SN, Aoyagi H, Yamasaki Y, Yoo JY, Park B, et al. The extracellular signal-regulated kinase mitogen-activated protein kinase/ribosomal S6 protein kinase 1 cascade phosphorylates cAMP response element-binding protein to induce MUC5B gene expression via D-prostanoid receptor signaling. J Biol Chem. 2011;286:34199-34214.
29. Schiller M, Dennler S, Anderegg U, Kokot A, Simon JC, Luger TA, et al. Increased cAMP levels modulate transforming growth factor-beta/Smad-induced expression of extracellular matrix components and other key fibroblast effector functions. J Biol Chem. 2010;285:409-421.